Treatment of chronic immune thrombocytopenic purpura: the patients' perspective. - Wikidata - awgldk - TriplyDB

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

http://www.wikidata.org/entity/Q33374397

about

Advances in ITP--therapy and quality of life--a patient survey Impact of chronic Immune Thrombocytopenic Purpura (ITP) on health-related quality of life: a conceptual model starting with the patient perspective.Rituximab in the treatment of autoimmune haematological disorders.A lower starting dose of eltrombopag is efficacious in Japanese patients with previously treated chronic immune thrombocytopenia.Patient-reported treatment burden of chronic immune thrombocytopenia therapies.Oral eltrombopag for up to three years is safe and well-tolerated in Japanese patients with previously treated chronic immune thrombocytopenia: an open-label, extension study.Health-related quality of life in adult patients with chronic immune thrombocytopenia in Serbia.

P2860

Q28742871-A11994EC-BCFD-43CF-91C5-4C37DFEA69EF Q33378585-20BD3939-7113-4537-9819-10653D6194B5 Q33378854-860E60B4-46E5-40C5-8B92-C05DAD8301BD Q33400203-7005DAB9-85C5-4B0E-B97A-E4BA2A2F69E5 Q33400348-4B820617-452A-46C4-A2D2-7B1557CA27BB Q33409401-436951B2-8077-4112-8178-88494DD7AC4D Q33411220-05B0DB4A-885C-4676-BEAA-78E2114C8317

P2860

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

http://www.wikidata.org/entity/Q33374397

description

2007 nî lūn-bûn

@nan

2007 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2007 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

name

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@ast

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@en

type

label

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@ast

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@en

prefLabel

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@ast

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@en

P1433

Q33374397-5F408811-D014-4BED-BB37-5CB4778D93A0

P1476

Q33374397-0632F5B6-4ADC-47CA-B6CB-CBCA53D31CFD

P2093

Q33374397-856F6CA1-EC5F-4FF5-841B-71D717C8239A

Q33374397-C7B647D6-C163-440A-A6EE-18238946D990

P2860

Q33374397-1A559BAC-3C2C-4244-A6FC-D27AE523BF09

Q33374397-33596766-EE8B-4679-9F65-0415BD530F68

Q33374397-3C17CE71-6B61-41DD-A21D-75D0C28F5D4C

Q33374397-403E54F0-1E07-4080-B11B-78C19F51C6C8

Q33374397-4B4E3B4B-6B6B-4FD8-9778-E7E77F75DB70

Q33374397-515A4DDE-612F-4E39-A3C5-4D12B5241E54

Q33374397-832FA5CB-8ED8-4BAD-A282-33E8DC726288

Q33374397-9C0A19B6-0CE9-486B-A7A5-AC93F0DE30F1

Q33374397-A2BC0850-09EF-4DA0-AE22-27F996C2A87D

Q33374397-A8AEA3AE-B513-42E7-BF39-C6E8FB6C4867

P304

Q33374397-F33CCC8E-4798-451D-BEDE-DF1D93892E25

P31

Q33374397-789F4F6D-A0A0-4641-9809-B95479E35DFD

P356

Q33374397-AD1CD602-8345-4E8A-B3ED-7DA4EF6DB820

P433

Q33374397-DFBEC48C-E14D-482A-868B-72CADD77DFE8

P478

Q33374397-F6036F2E-0B1A-4A32-98C7-2359AFF1036C

P577

Q33374397-B5BB946D-6F8F-47D8-8D49-6524B9482C2B

P698

Q33374397-96E5DB64-DF24-445C-BFEB-7860F9AD5F17

P921

Q33374397-52DAB582-8DA2-4181-9AD8-9AA52D7CB5F9

P356

J.1600-0609.2007.00829.X

P1433

European Journal of Haematology

P1476

Treatment of chronic immune thrombocytopenic purpura: the patients' perspective.

@en

P2093

Axel Matzdorff

http://www.w3.org/2001/XMLSchema#string

Gabriele Arnold

http://www.w3.org/2001/XMLSchema#string

P2860

Systematic review: efficacy and safety of rituximab for adults with idiopathic thrombocytopenic purpura.

Morbidity and mortality in adults with idiopathic thrombocytopenic purpura.

Rituximab chimeric anti-CD20 monoclonal antibody treatment for adults with chronic idiopathic thrombocytopenic purpura.

Newly diagnosed idiopathic thrombocytopenic purpura in childhood: an observational study.

Overview of 321 patients with idiopathic thrombocytopenic purpura. Retrospective analysis of the clinical features and response to therapy.

Long-term follow-up of chronic autoimmune thrombocytopenic purpura refractory to splenectomy: a prospective analysis.

Clinically significant newly presenting autoimmune thrombocytopenic purpura in adults: a prospective study of a population-based cohort of 245 patients.

Management of adult patients with persistent idiopathic thrombocytopenic purpura following splenectomy: a systematic review.

The efficacy and safety of B-cell depletion with anti-CD20 monoclonal antibody in adults with chronic immune thrombocytopenic purpura.

Splenectomy for adult patients with idiopathic thrombocytopenic purpura: a systematic review to assess long-term platelet count responses, prediction of response, and surgical complications.

P304

381-388

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/J.1600-0609.2007.00829.X

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

78

http://www.w3.org/2001/XMLSchema#string

P577

2007-02-27T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

17331128

http://www.w3.org/2001/XMLSchema#string

P921

thrombocytopenia